Background: The Montreal Cognitive Assessment (MoCA) has been recommended as a cognitive screening tool for clinical practice and research in Parkinson’s disease (PD), yet no normative data have been published for MoCA in PD without dementia.     Methods: We undertook a pooled secondary analysis of data from two studies (one cross-sectional design and one clinical trial) conducted in the East ...

background and purpose: cognitive impairment (ci) is one of the causes of disabilities in multiple sclerosis patients (ms). therefore, early detection and evaluation of cognitive performance is very important in patients with ms. the aim of the present study is to compare montreal cognitive assessment (moca) test and mini mental status exam (mmse) in relapsing remitting (rr) ms patients. method...

OBJECTIVE The Montreal Cognitive Assessment (MoCA) is an instrument that aids clinicians in detecting mild cognitive impairment and early Alzheimer's disease. The study aimed to adapt the MoCA for use in the Philippines, and determine its psychometric validity when used in the Filipino setting. METHODS The MoCA was adapted by a multidisciplinary team working at the Memory Center of St. Luke's...

BACKGROUND AND PURPOSE The National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization working group proposed a brief cognitive protocol for screening of vascular cognitive impairment. We investigated the validity, reliability, and feasibility of the Montreal Cognitive Assessment 5-minute protocol (MoCA 5-minute protocol) administe...

Modifier of cell adhesion (MOCA) is a member of the dedicator of cytokinesis 180 family of proteins and is highly expressed in CNS neurons. MOCA is associated with Alzheimer's disease tangles and regulates the accumulation of amyloid precursor protein and beta-amyloid. Here, we report that MOCA modulates cell-cell adhesion and morphology. MOCA increases the accumulation of adherens junction pro...

background: the purpose of this study is to investigate the relationship between the cognitive impairment and naa/cr and cho/cr ratios in the proton magnetic resonance spectroscopy (1hmrs), and to assess the importance of 1hmrs in the early diagnosis of cognitive impairment in patients with ischemic white matter lesions (wmls). materials and methods: a total of 45 patients (23males and 22 femal...

BACKGROUND Although the Montreal Cognitive Assessment (MoCA) is acknowledged as a promising neuropsychological tool, its normative data for older populations have not been established yet. The purpose of this study was to provide normative data for the MoCA in Japanese community-dwelling older people. METHODS In a Japanese town, 1,977 participants aged 65 years or older (mean age 73.6 years; ...

BACKGROUND The patients with obstructive sleep apnea hypopnea syndrome (OSAHS) tend to develop cognitive deficits, which usually go unrecognized, and can affect their daily life. The Beijing version of the Montreal cognitive assessment (MoCA-BJ), a Chinese version of MoCA, has been used for the assessment of cognitive functions of OSAHS patients in clinical practice. So far, its reliability and...

The Mini-Mental State Examination (MMSE) has been criticized as being an insufficient screening test for patients with vascular cognitive impairment because of its insensitivity to visuospatial and executive functional deficits. The Montreal Cognitive Assessment (MoCA) was designed to be more sensitive to such deficits, and thus may be a superior screening instrument for vascular cognitive impa...

AIMS To examine the effectiveness of the Montreal Cognitive Assessment (MoCA) to screen people with mild cognitive impairment (MCI), to associate the MoCA score with the presence of infarction, and to detect the characteristics of people with very mild subcortical vascular dementia (vmSVD). METHODS 392 out of 886 community dwellers aged 75 years and above living in Kurihara, Northern Japan, a...